[
Akeso Announces The Publication of Its Phase III Clinical Trial Results for Ivonescimab in Head-to-Head Comparison with Pembrolizumab in The Lancet
[og_img]
https://www.investing.com/news/press-releases/akeso-announces-the-publication-of-its-phase-iii-clinical-trial-results-for-ivonescimab-in-headtohead-comparison-with-pembrolizumab-in-the-lancet-93CH-3914050
Investing.com
Akeso Announces The Publication of Its Phase III Clinical Trial Results for Ivonescimab in Head-to-Head Comparison with Pembrolizumab in The Lancet
Related articles